AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Oct 21, 2016
5262_dirs_2016-10-21_320a670d-49e6-4941-a3ae-7d3158e5615b.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2189N
GlaxoSmithKline PLC
21 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr M M Slaoui
b)
Position/status
Chairman, Global Vaccines
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| $41.4815 | 10.943 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-10-20
f)
Place of the transaction
NYSE (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D E Troy
b)
Position/status
SVP & General Counsel
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| $41.4815 | 1,196.207 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-10-20
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr K Slaoui
b)
Position/status
PCA of Dr M M Slaoui (Chairman, Global Vaccines)
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| $41.4815 | 26.393 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-10-20
f)
Place of the transaction
NYSE (XNYS)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEFLFLQBFFFBB
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'Xd0GbeGuwBT0s2qQ1pfD5xGS5JRhtMtLLKAYfMF9OHiRXEoU8p-_VUCs3Q7xGEpNDMipBe4TTji2SrUjoEAqiGkvGKqDjjpLgJGlrm7MJb41:ULChSBTo8d4DSOk_kxfb2jYjkvVsLgxs5ifevHzNqjKVMBECRDhxAGRF9H-BPM-vnrsXBTZqDKmgV0M1C3RY7nhhvR61YcJxpE2oUr82N4U1'}});//]]>